depression, mood disorders, depressie, stemmingsstoornis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Subjects must be at least 18 but not older than 50 years of age. 2. Subjects must have given a written informed consent. 3. They must have good physical and mental health as determined by medical history and medical, ECG and laboratory examination. 4. Their Body Mass Index between 18.5-24.9.
Exclusion criteria
Exclusion criteria: 1. Known hypersensitivity to duloxetine or any of the inactive ingredients. 2. Contra-indications for duloxetine (hepatic impairment, severe renal impairment with a GFR 170 mm Hg; diastolic > 100 mm Hg; 13. Participation in another drug study within 3 months preceding this study; 14. Orthostatic dysregulation at the screening examination; 15. Uncontrolled Narrow-Angle Glaucoma; 16. Post-menopausal women, pregnant women, lactating women and women without adequate hormonal anticonception; 17. Inability to understand the nature and extent of the trial and the procedures required; 18. Inability to understand the procedures of the neuropsycholoigcal tests; 19. Contraindication to MRI.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Main outcome-measures consist of behavioral measures as well as statistical maps of the functional imaging data as measured by fMRI. Three tests will be administered targetting: - perception of emotionally valenced pictures - the processing of punishment and reward monetary reward task - memory bias with regards to emotional valence. | — |
Secondary
| Measure | Time frame |
|---|---|
| Behavioral measures on: mood, anxiety, and hostility. | — |
Contacts
Radboud University Nijmegen Medical Centre Department of Psychiatry, 966 PO Box 9101